Among the other tips on the WHO, there was the proposed addition of a footnote on the Plan I section of the Conference, stating that preparations containing predominantly cannabidiol and not over 0.two for each cent of delta-nine-tetrahydrocannabinol are certainly not below Intercontinental Management.[35] Nonetheless, the proposal was finally reje